0001127602-15-021324.txt : 20150624
0001127602-15-021324.hdr.sgml : 20150624
20150624180459
ACCESSION NUMBER: 0001127602-15-021324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150623
FILED AS OF DATE: 20150624
DATE AS OF CHANGE: 20150624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooke Shane
CENTRAL INDEX KEY: 0001524823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 15950156
MAIL ADDRESS:
STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST.
CITY: DUBLIN 2
STATE: L2
ZIP: 00000
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-06-23
0001520262
Alkermes plc.
ALKS
0001524823
Cooke Shane
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
President, Alkermes plc
Ordinary Shares
2015-06-23
4
M
0
18000
14.60
A
58640
D
Ordinary Shares
2015-06-23
4
S
0
17100
66.8007
D
41540
D
Ordinary Shares
2015-06-23
4
S
0
900
67.5622
D
40640
D
Employee Stock Option (Right to Buy)
14.60
2015-06-23
4
M
0
18000
0
D
2021-10-05
Ordinary Shares
18000
142000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.315 to $67.275. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.51 to $67.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing on 10/5/12.
/s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke
2015-06-24